Results 11 to 20 of about 85,603 (246)
Frontiers in Cellular and Infection Microbiology, 2022 Fungal infection is a serious global health issue, causing approximately 1.5 million mortalities annually. However, clinically available anti-fungal drugs are limited, especially for multidrug-resistant fungal infections.
Jiaying Lin +7 more
doaj +1 more source
Antifungal Polymeric Materials and Nanocomposites
Frontiers in Bioengineering and Biotechnology, 2021 Rising global populations due to medicinal advancements increases the patient population susceptible to superficial and severe fungal infections. Fungi often implicated in these diseases includes the dermatophytes (Microsporum spp., Epidermophtyon spp ...
Winnie Ntow-Boahene +2 more
doaj +1 more source
Fungal infections: Pathogenesis, antifungals and alternate treatment approaches
Current Research in Microbial Sciences, 2022 Increasing incidence of fungal infections of recent times requires immediate intervention. Fungal infections are seldom construed at initial stages that intensify the severity of infections and complicate the treatment procedures. Fungal pathogens employ
G.Kiran Kumar Reddy +2 more
doaj +1 more source
Marine Drugs, 2019 The mangrove ecosystem is a rich resource for the discovery of actinomycetes with potential applications in pharmaceutical science. Besides the genus Streptomyces, Micromonospora is also a source of new bioactive agents.
Rui-Jun Wang +8 more
doaj +1 more source
Metabolic Engineering Communications, 2019 In pharmaceutical industry, isepamicin is mainly manufactured from gentamicin B, which is produced by Micromonospora echinospora as a minor component of the gentamicin complex.
Yingying Chang +8 more
doaj +1 more source
Frontiers in Cellular and Infection Microbiology, 2022 Occurrence and intensity of systemic invasive fungal infections have significantly risen in recent decades with large amount of mortality and morbidity rates at global level.
Kavitha Dhandapani +3 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Aims: We aimed to estimate the risk of drug-induced liver injury (DILI) from various antifungal treatments with azoles and echinocandins causing in real-world practice.Methods: We performed disproportionality and Bayesian analyses based on data from the ...
Zhi-Xuan Zhou +13 more
doaj +1 more source
Applied and Environmental Soil Science, 2021 The occurrence of residual antifungal agents through indiscriminate prophylactic use and inappropriate disposal has been reported in wastewater treatment plants (WWTPs), surface water, and groundwater environments. Opportunistic pathogenic aquatic yeasts
Mzimkhulu E. Monapathi +6 more
doaj +1 more source
Identification and Elimination of Antifungal Tolerance in Candida auris
Biomedicines, 2023 Antimicrobial resistance is a global health crisis to which pathogenic fungi make a substantial contribution. The human fungal pathogen C. auris is of particular concern due to its rapid spread across the world and its evolution of multidrug resistance ...
Samira Rasouli Koohi +3 more
doaj +1 more source
Heliyon, 2020 The human pathogenic yeast genus Malassezia may be an etiological agent of skin disorders and has received considerable attention from dermatologists in recent years.
Kaiqin Wang +12 more
doaj +1 more source